In vivo PET imaging of histone deacetylases by 18F- suberoylanilide hydroxamic acid (18F-SAHA)

Journal of Medicinal Chemistry

Volumn 54, Issue 15, 2011, Pages 5576-5582

  Hendricks, J Adam ^a   Keliher, Edmund J ^a   Marinelli, Brett ^a   Reiner, Thomas ^a   Weissleder, Ralph ^a   Mazitschek, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18 SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE 8; RADIOISOTOPE; UNCLASSIFIED DRUG; VORINOSTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG DISTRIBUTION; DRUG POTENCY; DRUG SCREENING; DRUG TARGETING; IN VIVO STUDY; MOUSE; NONHUMAN; OVARY CANCER; POSITRON EMISSION TOMOGRAPHY;

ANIMALS; FLUORINE RADIOISOTOPES; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; MICE; MICE, INBRED C57BL;

EID: 79961222441     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm200620f     Document Type: Article

References (26)

1. Haberland, M.; Montgomery, R. L.; Olson, E. N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy Nat. Rev. Genet. 2009, 10, 32-42
2. Minucci, S.; Pelicci, P. G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer Nat. Rev. Cancer 2006, 6, 38-51 (Pubitemid 43054973)
3. Choudhary, C.; Kumar, C.; Gnad, F.; Nielsen, M. L.; Rehman, M.; Walther, T. C.; Olsen, J. V.; Mann, M. Lysine acetylation targets protein complexes and co-regulates major cellular functions Science 2009, 325, 834-840
4. Gregoretti, I.; Lee, Y.-M.; Goodson, H. V. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis J. Mol. Biol. 2004, 338, 17-31 (Pubitemid 38429783)
5. Haigis, M. C.; Sinclair, D. A. Mammalian sirtuins: biological insights and disease relevance Annu. Rev. Pathol.: Mech. Dis. 2010, 5, 253-295
6. Richon, V. M.; Webb, Y.; Merger, R.; Sheppard, T.; Jursic, B.; Ngo, L.; Civoli, F.; Breslow, R.; Rifkind, R. A.; Marks, P. A. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 5705-5708 (Pubitemid 26191313)
7. Taunton, J.; Hassig, C. A.; Schreiber, S. L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p Science 1996, 272, 408-411 (Pubitemid 26138177)
8. Shao, Y.; Gao, Z.; Marks, P. A.; Jiang, X. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 18030-18035 (Pubitemid 40054069)
9. Bernstein, B. E.; Meissner, A.; Lander, E. S. The mammalian epigenome Cell 2007, 128, 669-681 (Pubitemid 46273573)
10. Feng, D.; Liu, T.; Sun, Z.; Bugge, A.; Mullican, S. E.; Alenghat, T.; Liu, X. S.; Lazar, M. A. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism Science 2011, 331, 1315-1319
11. Zhong, L.; Urso, A. D.; Toiber, D.; Sebastian, C.; Henry, R. E.; Vadysirisack, D. D.; Guimaraes, A.; Marinelli, B.; Wikstrom, J. D.; Nir, T.; Clish, C. B.; Vaitheesvaran, B.; Iliopoulos, O.; Kurland, I.; Dor, Y.; Weissleder, R.; Shirihai, O. S.; Ellisen, L. W.; Espinosa, J. M.; Mostoslavsky, R. The Histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha Cell 2010, 140, 280-293
12. Guan, J.-S.; Haggarty, S. J.; Giacometti, E.; Dannenberg, J.-H.; Joseph, N.; Gao, J.; Nieland, T. J. F.; Zhou, Y.; Wang, X.; Mazitschek, R.; Bradner, J. E.; DePinho, R. A.; Jaenisch, R.; Tsai, L.-H. HDAC2 negatively regulates memory formation and synaptic plasticity Nature 2009, 459, 55-60
13. Kim, D.; Frank, C. L.; Dobbin, M. M.; Tsunemoto, R. K.; Tu, W.; Peng, P. L.; Guan, J.-S.; Lee, B.-H.; Moy, L. Y.; Giusti, P.; Broodie, N.; Mazitschek, R.; Delalle, I.; Haggarty, S. J.; Neve, R. L.; Lu, Y.; Tsai, L.-H. Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity Neuron 2008, 60, 803-817
14. de Zoeten, E. F.; Wang, L.; Butler, K.; Beier, U. H.; Akimova, T.; Sai, H.; Bradner, J. E.; Mazitschek, R.; Kozikowski, A. P.; Matthias, P.; Hancock, W. W. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells Mol. Cell. Biol. 2011, 31, 2066-2078
15. Wang, L.; de Zoeten, E. F.; Greene, M. I.; Hancock, W. W. Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells Nat. Rev. Drug Discovery 2009, 8, 969-981
16. Patel, V.; Mazitschek, R.; Coleman, B.; Nguyen, C.; Urgaonkar, S.; Cortese, J. F.; Barker, R. H.; Greenberg, E.; Tang, W.; Bradner, J. E.; Schreiber, S. L.; Duraisingh, M. T.; Wirth, D. F.; Clardy, J. Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum J. Med. Chem. 2009, 52, 2185-2187
17. Wiech, N. L.; Fisher, J. F.; Helquist, P.; Wiest, O. Inhibition of histone deacetylases: a pharmacological approach to the treatment of non-cancer disorders Curr. Top. Med. Chem. 2009, 9, 257-271
18. Bradner, J. E.; West, N.; Grachan, M. L.; Greenberg, E. F.; Haggarty, S. J.; Warnow, T.; Mazitschek, R. Chemical phylogenetics of histone deacetylases Nat. Chem. Biol. 2010, 6, 238-243
19. Weichert, W. HDAC expression and clinical prognosis in human malignancies Cancer Lett. 2009, 280, 168-176
20. O'Connor, O. A.; Heaney, M. L.; Schwartz, L.; Richardson, S.; Willim, R.; MacGregor-Cortelli, B.; Curly, T.; Moskowitz, C.; Portlock, C.; Horwitz, S.; Zelenetz, A. D.; Frankel, S.; Richon, V.; Marks, P.; Kelly, W. K. Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies J. Clin. Oncol. 2006, 24, 166-173 (Pubitemid 46630509)
21. Reid, A. E.; Hooker, J.; Shumay, E.; Logan, J.; Shea, C.; Kim, S. W.; Collins, S.; Xu, Y.; Volkow, N.; Fowler, J. S. Evaluation of 6-([(18)F]fluoroacetamido)-1-hexanoicanilide for PET imaging of histone deacetylase in the baboon brain Nucl. Med. Biol. 2009, 36, 247-258
22. 11C]MS-275 using positron emission tomography ACS Chem. Neurosci. 2010, 1, 65-73
23. Sankaranarayanapillai, M.; Tong, W. P.; Yuan, Q.; Bankson, J. A.; Dafni, H.; Bornmann, W. G.; Soghomonyan, S.; Pal, A.; Ramirez, M. S.; Webb, D.; Kaluarachchi, K.; Gelovani, J. G.; Ronen, S. M. Monitoring histone deacetylase inhibition in vivo: noninvasive magnetic resonance spectroscopy method Mol. Imaging 2008, 7, 92-100
24. Lahm, A.; Paolini, C.; Pallaoro, M.; Nardi, M. C.; Jones, P. A.; Neddermann, P.; Sambucini, S.; Bottomley, M. J.; Lo Surdo, P.; Carfi, A.; Koch, U.; De Francesco, R.; Steinkuhler, C.; Gallinari, P. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 17335-17340 (Pubitemid 350219843)
25. Gediya, L. K.; Chopra, P.; Purushottamachar, P.; Maheshwari, N.; Njar, V. C. O. A new simple and high-yield synthesis of suberoylanilide hydroxamic acid and its inhibitory effect alone or in combination with retinoids on proliferation of human prostate cancer cells J. Med. Chem. 2005, 48, 5047-5051 (Pubitemid 41033145)
26. 18F]fluoroaniline J. Labelled Compd. Radiopharm. 2006, 49, 1037-1050 (Pubitemid 46141412)